<DOC>
	<DOCNO>NCT01121900</DOCNO>
	<brief_summary>The objective study compare pharmacokinetic profile test product , 300 mg trazodone hydrochloride ( HCl ) extended-release caplets ( contain Contramid® ) , administer single dose , reference product , 100 mg trazodone HCl immediate-release tablet ( Apotex Corp ) , administer three time daily . For purpose rate extent absorption trazodone formation m-chlorophenylpiperazine ( mCPP ) administration two formulation , compare fasting condition .</brief_summary>
	<brief_title>A Study Compare Bioavailability 300 mg Trazodone Hydrochloride Extended-release Caplets 100 mg Trazodone Hydrochloride Immediate-release Tablets ( Administered Three Times Daily )</brief_title>
	<detailed_description />
	<mesh_term>Trazodone</mesh_term>
	<criteria>Healthy male female subject 18 &lt; 56 year age . Body mass within 10 % ideal mass relation height age , accord Body Mass Index . Body mass le 53 kg . Findings within range clinical acceptability medical history physical examination , laboratory result within laboratory reference range relevant laboratory test ( unless investigator consider deviation irrelevant purpose study ) . Normal 12lead electrocardiogram ( ECG ) vital sign , abnormality , investigator consider disqualification participation study . Willingness undergo pre poststudy physical examination laboratory investigation . Ability comprehend willingness sign statement inform consent ( screen periodrelated procedure ) . Nonsmoker past smoker stop use form tobacco , include snuff similar product , least 3 month enter study . For female , follow condition meet : 1 . Had surgically sterilize undergone hysterectomy , 2 . Was childbearing potential , follow condition meet : 1 . Had negative pregnancy test screening . If test positive , subject exclude study receive study medication . In rare circumstance pregnancy discover subject receive study medication , every attempt make follow subject term . 2 . Had agree use accept method contraception ( i.e. , spermicide barrier method spermicide nonhormonal intrauterine contraceptive device ) . The subject agree continue method throughout study . Hormonal contraceptives allow . 3 . Females childbearing potential could also include menstrual period one year consider postmenopausal . Evidence psychiatric disorder , antagonistic personality , poor motivation , emotional intellectual problem likely limited validity consent participate study limit ability comply protocol requirement . History , current compulsive alcohol abuse ( &gt; 10 drink weekly ) , regular exposure substance abuse . Use medication , prescribed overthecounter , within 2 week prior first administration study medication except would affect outcome study opinion investigator . Hormonal contraceptive agent allow . Participation another study experimental drug , last administration ( previous study medication ) within 8 week first administration study medication . Treatment within previous 3 month drug welldefined potential adversely affect major organ system . A major illness 3 month commencement screening period . History hypersensitivity study medication relate medication . History bronchial asthma . History epilepsy . History porphyria . Relevant history laboratory clinical finding indicative acute chronic disease , likely influence study outcome . Donation loss blood equal exceed 500 mL 8 week first administration study medication . Diagnosis hypotension make screening period . Diagnosis hypertension make screening period current diagnosis hypertension . Resting pulse &gt; 100 beat per minute &lt; 40 beat per minute screening period , either supine standing . Positive test HIV and/or Hepatitis B and/or Hepatitis C. Positive urine screen drug abuse . Positive urine screen tobacco use . A serum pregnancy test ( beta human chorionic gonadotropin [ βHCG ] ) either positive perform lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Healthy subject</keyword>
</DOC>